LITTLE KNOWN FACTS ABOUT CONOLIDINE.

Elucidating the specific pharmacological mechanism of action (MOA) of Normally developing compounds can be challenging. Despite the fact that Tarselli et al. (60) produced the very first de novo synthetic pathway to conolidine and showcased that this naturally transpiring compound successfully suppresses responses to the two chemically induced and